Home / SRTS : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SRTS make money? Does SRTS have pricing power? What's the Earnings Whisper? Will SRTS profit more as the business scales? What is SRTS's management track record? Is SRTS's current price justified?

Sensus Healthcare, Inc.

$3.16 -$0.94 (-22.93%)

NASDAQ · 15 Sep 2026 18:04 UTC

Previous Close

$3.13

Day Range

$3.1$3.19

Year Range

$2.66$5.49

Market Cap

52.02M

AVG Volume

50.52K

Trailing/Forward PE

-3.35/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

NASDAQ

Revenue (USD)

SRTS Revenue (USD) by year
Period	Revenue (USD)
2025	27.48M
2024	41.81M
2023	24.41M
2022	44.53M
2021	27.04M
2020	9.58M
2019	27.26M
2018	26.43M
2017	20.59M
2016	14.81M

Net Income (USD)

SRTS Net Income (USD) by year
Period	Net Income (USD)
2025	-7.72M
2024	6.65M
2023	485K
2022	24.24M
2021	4.12M
2020	-6.83M
2019	-1.7M
2018	-2.02M
2017	-3.71M
2016	-346.45K

Operating Income (USD)

SRTS Operating Income (USD) by year
Period	Operating Income (USD)
2025	-10.31M
2024	8.09M
2023	-384K
2022	14.83M
2021	4.12M
2020	-8.23M
2019	-1.97M
2018	-2.01M
2017	-3.72M
2016	-363.12K

EBITDA (USD)

SRTS EBITDA (USD) by year
Period	EBITDA (USD)
2025	-6.19M
2024	9.45M
2023	1.02M
2022	28.31M
2021	4.73M
2020	-6.15M
2019	-1.23M
2018	-1.21M
2017	-3.25M
2016	13K

Cash Flows (USD)

SRTS Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	332K
2024	-1.11M
2023	-2.37M
2022	-1.57M
2021	-414K
2020	-793.05K
2019	-2.51M
2018	-9.42M
2017	-3.34M
2016	-1.14M

EPS (USD)

SRTS EPS (USD) by year
Period	EPS (USD)
2025	-0.47
2024	0.41
2023	0.03
2022	1.46
2021	0.25
2020	-0.42
2019	-0.1
2018	-0.15
2017	-0.28
2016	-0.03

Expenses (USD)

SRTS Expenses (USD) by year
Period	Expenses (USD)
2025	22.37M
2024	16.62M
2023	14.67M
2022	14.96M
2021	12.99M
2020	13.84M
2019	19.93M
2018	19.77M
2017	17.81M
2016	10.49M

Cash & Debt (USD)

SRTS Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	22.08M
2024	22.06M
2023	23.15M
2022	25.52M
2021	14.52M
2020	14.91M
2019	15.49M
2018	15.38M
2017	11.19M
2016	11.5M

Debt ratios

SRTS Debt ratios by year
Period	Debt ratios
2025	-0.66
2024	-0.49
2023	-0.8
2022	-0.95
2021	3.71
2020	1.14
2019	2.48
2018	3.53

Margins

SRTS Margins by year
Period	Margins
2025	43.18%
2024	58.44%
2023	57.61%
2022	66.53%
2021	62.82%
2020	54.82%
2019	64.4%
2018	63.99%
2017	67.03%
2016	66.48%

Return on Capital

SRTS Return on Capital by year
Period	Return on Capital
2025	-16.05%
2024	11.91%
2023	0.99%
2022	50.44%
2021	15.83%
2020	-31.79%
2019	-6.07%
2018	-7.64%
2017	-31.77%
2016	-2.27%

Shares Outstanding

SRTS Shares Outstanding by year
Period	Shares Outstanding
2025	16.33M
2024	16.33M
2023	16.27M
2022	16.42M
2021	16.49M
2020	16.45M
2019	16.04M
2018	15.95M
2017	13.25M
2016	13.25M

Book Value Per Share (USD)

SRTS Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	2.95
2024	3.42
2023	3
2022	2.93
2021	1.58
2020	1.31
2019	1.75
2018	1.66
2017	0.88
2016	1.15

Total Assets (USD)

SRTS Total Assets (USD) by year
Period	Total Assets (USD)
2025	53.04M
2024	62.16M
2023	53.71M
2022	56.73M
2021	32.24M
2020	28.01M
2019	36.92M
2018	33.25M
2017	18.84M
2016	18.95M

Employee Count

SRTS Employee Count by year
Period	Employee Count
2025	60
2024	54
2023	35
2022	42
2021	37
2020	42
2019	53
2018	48
2017	45
2016	37

PE Ratio

SRTS PE Ratio by year
Period	PE Ratio
Aug 25	31.43
Aug 25	50.54
Jul 25	49.91
Jul 25	39.31
Jul 25	37.68
Jul 25	42.21
Jun 25	44.02
Jun 25	42.84
Jun 25	43.57
Jun 25	44.56
May 25	43.11
May 25	42.48
May 25	40.4
May 25	11.03
May 25	10.64
Apr 25	11.65
Apr 25	11.28
Apr 25	11.33
Apr 25	10.96
Mar 25	11.72
Mar 25	11.57
Mar 25	11.43
Mar 25	11.3
Feb 25	8.38
Feb 25	9.43
Feb 25	9.66
Feb 25	10.24
Jan 25	14.44
Jan 25	12.52
Jan 25	11.5
Jan 25	11.46
Jan 25	12.71
Dec 24	12.64
Dec 24	12.45
Dec 24	14.3
Dec 24	15.48
Nov 24	14.92
Nov 24	15.58
Nov 24	13.39
Nov 24	16.61
Nov 24	16.11
Oct 24	15.62
Oct 24	16.31
Oct 24	16.24
Oct 24	15.43
Sep 24	14.42
Sep 24	14.23
Sep 24	14.94
Sep 24	13.54
Aug 24	15.99
Aug 24	16.14
Aug 24	15.89
Aug 24	22.38
Aug 24	21.05
Jul 24	21.96
Jul 24	21.01
Jul 24	21.61
Jul 24	18.74
Jun 24	18.67
Jun 24	18.32
Jun 24	18.56
Jun 24	19.3
May 24	18.98
May 24	21.36
May 24	20.77
May 24	18.53
May 24	122.45
Apr 24	114.4
Apr 24	110.38
Apr 24	113.39
Apr 24	115.74
Mar 24	127.48
Mar 24	126.48
Mar 24	118.09
Nov 23	12.95
Nov 23	15
Oct 23	14.93
Oct 23	16.02
Oct 23	16.43
Oct 23	18.06
Sep 23	18.88
Sep 23	17.86
Sep 23	18.61
Sep 23	19.36
Sep 23	21.27
Aug 23	20.65
Aug 23	21.2
Aug 23	22.97
Aug 23	8.01
Jul 23	7.49
Jul 23	7.83
Jul 23	7.98
Jul 23	8.47
Jun 23	8.14
Jun 23	7.18
Jun 23	7.54
Jun 23	7.41
Jun 23	6.98
May 23	6.92
May 23	7.23

Free Cash Flow Yield

SRTS Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-13.51%
Sep 26	-13.42%
Sep 26	-13.25%
Aug 26	-12.01%
Aug 26	-12.66%
Aug 26	-14.78%
Aug 26	-1.46%
Jul 26	-1.54%
Jul 26	-1.48%
Jul 26	-1.49%
Jul 26	-1.47%
Jul 26	-1.46%
Jun 26	-1.48%
Jun 26	-1.61%
Jun 26	-1.66%
Jun 26	-1.66%
May 26	-1.45%
May 26	-1.41%
May 26	-1.25%
May 26	0.66%
May 26	0.51%
Apr 26	0.52%
Apr 26	0.45%
Apr 26	0.45%
Apr 26	0.49%
Mar 26	0.52%
Mar 26	0.53%
Mar 26	0.52%
Mar 26	0.48%
Feb 26	3.23%
Feb 26	3.36%
Feb 26	3.44%
Feb 26	2.63%
Jan 26	2.59%
Jan 26	2.75%
Jan 26	2.5%
Jan 26	2.79%
Jan 26	3.24%
Dec 25	3.5%
Dec 25	3.47%
Dec 25	3.47%
Dec 25	3.4%
Nov 25	3.17%
Nov 25	3.3%
Nov 25	3.07%
Nov 25	5.09%
Oct 25	6.71%
Oct 25	6.41%
Oct 25	6.69%
Oct 25	6.52%
Oct 25	6.24%
Sep 25	6.9%
Sep 25	6.88%
Sep 25	6.73%
Sep 25	6.62%
Aug 25	6.31%
Aug 25	6.58%
Aug 25	6.39%
Aug 25	8.18%
Aug 25	5.09%
Jul 25	5.15%
Jul 25	6.54%
Jul 25	6.82%
Jul 25	6.09%
Jun 25	5.84%
Jun 25	6%
Jun 25	5.9%
Jun 25	5.77%
May 25	5.96%
May 25	6.05%
May 25	6.36%
May 25	-1.51%
May 25	-1.57%
Apr 25	-1.43%
Apr 25	-1.48%
Apr 25	-1.47%
Apr 25	-1.52%
Mar 25	-1.42%
Mar 25	-1.44%
Mar 25	-1.46%
Mar 25	-1.47%
Feb 25	2.68%
Feb 25	2.38%
Feb 25	2.33%
Feb 25	2.19%
Jan 25	1.55%
Jan 25	1.79%
Jan 25	1.95%
Jan 25	1.96%
Jan 25	1.77%
Dec 24	1.78%
Dec 24	1.8%
Dec 24	1.57%
Dec 24	1.45%
Nov 24	1.51%
Nov 24	1.44%
Nov 24	1.68%
Nov 24	-0.99%
Nov 24	-1.02%
Oct 24	-1.05%

Price to Sales

SRTS Price to Sales by year
Period	Price to Sales
Sep 26	2.94
Sep 26	2.96
Sep 26	3
Aug 26	3.31
Aug 26	3.14
Aug 26	2.69
Aug 26	2.24
Jul 26	2.13
Jul 26	2.21
Jul 26	2.21
Jul 26	2.23
Jul 26	2.24
Jun 26	2.22
Jun 26	2.04
Jun 26	1.98
Jun 26	1.97
May 26	2.26
May 26	2.33
May 26	2.64
May 26	1.83
May 26	2.36
Apr 26	2.34
Apr 26	2.67
Apr 26	2.67
Apr 26	2.44
Mar 26	2.33
Mar 26	2.3
Mar 26	2.31
Mar 26	2.52
Feb 26	1.88
Feb 26	1.81
Feb 26	1.77
Feb 26	2.31
Jan 26	2.35
Jan 26	2.21
Jan 26	2.43
Jan 26	2.18
Jan 26	1.88
Dec 25	1.74
Dec 25	1.76
Dec 25	1.76
Dec 25	1.79
Nov 25	1.92
Nov 25	1.84
Nov 25	1.98
Nov 25	1.82
Oct 25	1.39
Oct 25	1.45
Oct 25	1.39
Oct 25	1.43
Oct 25	1.49
Sep 25	1.35
Sep 25	1.35
Sep 25	1.38
Sep 25	1.4
Aug 25	1.47
Aug 25	1.41
Aug 25	1.46
Aug 25	1.43
Aug 25	2.31
Jul 25	2.28
Jul 25	1.79
Jul 25	1.72
Jul 25	1.93
Jun 25	2.01
Jun 25	1.95
Jun 25	1.99
Jun 25	2.03
May 25	1.97
May 25	1.94
May 25	1.84
May 25	1.75
May 25	1.69
Apr 25	1.85
Apr 25	1.79
Apr 25	1.8
Apr 25	1.74
Mar 25	1.86
Mar 25	1.84
Mar 25	1.82
Mar 25	1.8
Feb 25	1.89
Feb 25	2.13
Feb 25	2.18
Feb 25	2.31
Jan 25	3.26
Jan 25	2.82
Jan 25	2.59
Jan 25	2.58
Jan 25	2.86
Dec 24	2.85
Dec 24	2.81
Dec 24	3.22
Dec 24	3.49
Nov 24	3.36
Nov 24	3.51
Nov 24	3.02
Nov 24	3.03
Nov 24	2.94
Oct 24	2.85

EV/EBITDA

SRTS EV/EBITDA by year
Period	EV/EBITDA
Nov 25	999.51
Oct 25	648.81
Oct 25	700.89
Oct 25	652.28
Oct 25	680.06
Oct 25	732.14
Sep 25	617.56
Sep 25	621.03
Sep 25	645.33
Sep 25	662.7
Aug 25	718.25
Aug 25	669.64
Aug 25	704.36
Aug 25	9.75
Aug 25	18.53
Jul 25	18.24
Jul 25	13.37
Jul 25	12.62
Jul 25	14.7
Jun 25	15.53
Jun 25	14.99
Jun 25	15.33
Jun 25	15.78
May 25	15.12
May 25	14.83
May 25	13.87
May 25	5.49
May 25	5.21
Apr 25	5.92
Apr 25	5.66
Apr 25	5.7
Apr 25	5.44
Mar 25	5.97
Mar 25	5.87
Mar 25	5.76
Mar 25	5.68
Feb 25	4.23
Feb 25	4.96
Feb 25	5.12
Feb 25	5.53
Jan 25	8.48
Jan 25	7.13
Jan 25	6.42
Jan 25	6.39
Jan 25	7.26
Dec 24	7.21
Dec 24	7.08
Dec 24	8.38
Dec 24	9.21
Nov 24	8.81
Nov 24	9.28
Nov 24	7.74
Nov 24	9.27
Nov 24	8.94
Oct 24	8.61
Oct 24	9.07
Oct 24	9.02
Oct 24	8.48
Sep 24	7.81
Sep 24	7.68
Sep 24	8.15
Sep 24	7.22
Aug 24	8.86
Aug 24	8.96
Aug 24	8.79
Aug 24	13.13
Aug 24	12.23
Jul 24	12.85
Jul 24	12.21
Jul 24	12.61
Jul 24	10.66
Jun 24	10.62
Jun 24	10.38
Jun 24	10.54
Jun 24	11.04
May 24	10.83
May 24	12.44
May 24	12.04
May 24	10.52
May 24	36.23
Apr 24	32.41
Apr 24	30.5
Apr 24	31.93
Apr 24	33.04
Mar 24	38.62
Mar 24	38.14
Mar 24	34.16
Nov 23	3.43
Nov 23	4.86
Oct 23	4.81
Oct 23	5.57
Oct 23	5.85
Oct 23	7
Sep 23	7.57
Sep 23	6.85
Sep 23	7.38
Sep 23	7.9
Sep 23	9.23
Aug 23	8.81
Aug 23	9.19

Price/Operating Cashflow

SRTS Price/Operating Cashflow by year
Period	Price/Operating Cashflow
May 26	95.24
May 26	123.06
Apr 26	121.83
Apr 26	138.83
Apr 26	138.83
Apr 26	127.08
Mar 26	121.21
Mar 26	119.66
Mar 26	120.28
Mar 26	131.41
Feb 26	35.17
Feb 26	33.8
Feb 26	33.03
Feb 26	43.13
Jan 26	43.9
Jan 26	41.33
Jan 26	45.35
Jan 26	40.73
Jan 26	35.08
Dec 25	32.43
Dec 25	32.77
Dec 25	32.77
Dec 25	33.37
Nov 25	35.85
Nov 25	34.4
Nov 25	36.97
Nov 25	19.22
Oct 25	14.6
Oct 25	15.29
Oct 25	14.65
Oct 25	15.01
Oct 25	15.7
Sep 25	14.19
Sep 25	14.23
Sep 25	14.55
Sep 25	14.78
Aug 25	15.51
Aug 25	14.87
Aug 25	15.33
Aug 25	12.1
Aug 25	19.45
Jul 25	19.21
Jul 25	15.13
Jul 25	14.5
Jul 25	16.25
Jun 25	16.94
Jun 25	16.49
Jun 25	16.77
Jun 25	17.15
May 25	16.59
May 25	16.35
May 25	15.55
Feb 25	29.28
Feb 25	32.96
Feb 25	33.76
Feb 25	35.78
Jan 25	50.48
Jan 25	43.74
Jan 25	40.19
Jan 25	40.07
Jan 25	44.42
Dec 24	44.17
Dec 24	43.5
Dec 24	49.99
Dec 24	54.1
Nov 24	52.14
Nov 24	54.47
Nov 24	46.81
Mar 23	12.17
Mar 23	12.6
Mar 23	14.69
Feb 23	16.26
Feb 23	17.43
Feb 23	16.76
Feb 23	21.02
Jan 23	20.95
Jan 23	21.79
Jan 23	21.12
Jan 23	19.86
Dec 22	17.67
Dec 22	16.43
Dec 22	15.29
Dec 22	14.19
Dec 22	15.93
Nov 22	15.26
Nov 22	15.45
Nov 22	18.05
Nov 22	23.5
Oct 22	51.85
Oct 22	48.77
Oct 22	43.17
Oct 22	44.21
Sep 22	46.44
Sep 22	45.84
Sep 22	54.85
Sep 22	48.29
Sep 22	46.44
Aug 22	48.81
Aug 22	48.21
Aug 22	55.48

Price to Book

SRTS Price to Book by year
Period	Price to Book
Sep 26	1.4
Sep 26	1.41
Sep 26	1.42
Aug 26	1.57
Aug 26	1.49
Aug 26	1.28
Aug 26	1.11
Jul 26	1.05
Jul 26	1.1
Jul 26	1.09
Jul 26	1.1
Jul 26	1.11
Jun 26	1.1
Jun 26	1.01
Jun 26	0.98
Jun 26	0.98
May 26	1.12
May 26	1.15
May 26	1.3
May 26	1.05
May 26	1.35
Apr 26	1.34
Apr 26	1.52
Apr 26	1.52
Apr 26	1.4
Mar 26	1.33
Mar 26	1.31
Mar 26	1.32
Mar 26	1.44
Feb 26	1.31
Feb 26	1.26
Feb 26	1.23
Feb 26	1.61
Jan 26	1.64
Jan 26	1.54
Jan 26	1.69
Jan 26	1.52
Jan 26	1.31
Dec 25	1.21
Dec 25	1.22
Dec 25	1.22
Dec 25	1.24
Nov 25	1.34
Nov 25	1.28
Nov 25	1.38
Nov 25	1.32
Oct 25	1
Oct 25	1.05
Oct 25	1
Oct 25	1.03
Oct 25	1.08
Sep 25	0.97
Sep 25	0.97
Sep 25	1
Sep 25	1.01
Aug 25	1.06
Aug 25	1.02
Aug 25	1.05
Aug 25	1.07
Aug 25	1.72
Jul 25	1.69
Jul 25	1.33
Jul 25	1.28
Jul 25	1.43
Jun 25	1.49
Jun 25	1.45
Jun 25	1.48
Jun 25	1.51
May 25	1.46
May 25	1.44
May 25	1.37
May 25	1.31
May 25	1.27
Apr 25	1.39
Apr 25	1.34
Apr 25	1.35
Apr 25	1.3
Mar 25	1.4
Mar 25	1.38
Mar 25	1.36
Mar 25	1.35
Feb 25	1.44
Feb 25	1.62
Feb 25	1.66
Feb 25	1.76
Jan 25	2.48
Jan 25	2.15
Jan 25	1.98
Jan 25	1.97
Jan 25	2.19
Dec 24	2.17
Dec 24	2.14
Dec 24	2.46
Dec 24	2.66
Nov 24	2.57
Nov 24	2.68
Nov 24	2.3
Nov 24	2.09
Nov 24	2.02
Oct 24	1.96

No video analysis for this stock yet. Request one from our team.

News: SRTS

marketbeat.com · 13 Aug 2026

Sensus Healthcare Q2 Earnings Call Highlights

Sensus Healthcare NASDAQ: SRTS reported second-quarter revenue of $2.3 million, down from $7.3 million a year earlier, as delayed third-party financing prevented the company from recognizing revenue tied to eight equipment units before the end of June.

seekingalpha.com · 13 Aug 2026

Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript

businesswire.com · 13 Aug 2026

Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended June 30, 2026. Highlights included: Revenues of $2.3 million for the quarter ended June 30, 2026, a decrease of $5.0 million, from the 2025 quarter. The decrease was driven by a lower number of un.

businesswire.com · 30 Jul 2026

Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the second quarter of 2026 on Thursday, August 13, 2026. Management will hold a conference call beginning at 4:30 pm Eastern time to review the results, provide a business update and answer questions.Participants are enc.